Evidence map›Paper›PMID 35163094›Full record

ArticleInternational journal of molecular sciences2022

Protein Dimerization via Tyr Residues: Highlight of a Slow Process with Co-Existence of Numerous Intermediates and Final Products.

Anouchka Gatin, Patricia Duchambon, Guillaume van der Rest, Isabelle Billault, Cécile Sicard-Roselli

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anouchka GatinUniversité Paris-Saclay, CNRS, Institut de Chimie Physique UMR 8000, CEDEX, 91405 Orsay, France.
Patricia DuchambonUniversité Paris-Saclay, CNRS, Institut Curie UMR 9187, INSERM U1196, CEDEX, 91405 Orsay, France.
Guillaume van der RestUniversité Paris-Saclay, CNRS, Institut de Chimie Physique UMR 8000, CEDEX, 91405 Orsay, France.ORCID 0000-0002-1176-620X
Isabelle BillaultUniversité Paris-Saclay, CNRS, Institut de Chimie Physique UMR 8000, CEDEX, 91405 Orsay, France.ORCID 0000-0001-5817-9398
Cécile Sicard-RoselliUniversité Paris-Saclay, CNRS, Institut de Chimie Physique UMR 8000, CEDEX, 91405 Orsay, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein dimerization via tyrosine residues is a crucial process in response to an oxidative attack, which has been identified in many ageing-related pathologies. Recently, it has been found that for isolated tyrosine amino acid, dimerization occurs through three types of tyrosine-tyrosine crosslinks and leads to at least four final products. Herein, considering two protected tyrosine residues, tyrosine-containing peptides and finally proteins, we investigate the dimerization behavior of tyrosine when embedded in a peptidic sequence. After azide radical oxidation and by combining UPLC-MS and H/D exchange analyzes, we were able to evidence: (i) the slow kinetics of Michael Addition Dimers (MAD) formation, i.e., more than 48 h; (ii) the co-existence of intermediates and final cyclized dimer products; and (iii) the probable involvement of amide functions to achieve Michael additions even in proteins. This raises the question of the possible in vivo existence of both intermediates and final entities as well as their toxicity and the potential consequences on protein structure and/or function.

Indexed as

Protein MultimerizationCalcium-Binding ProteinsCalmodulinCell Cycle ProteinsHumansOxidation-ReductionPeptide FragmentsTyrosineCalcium-Binding ProteinsCalmodulinCell Cycle ProteinsCETN2 protein, humanPeptide FragmentsTyrosineoxidative stressproteinsradicalstyrosine dimers

Identifiers

PMID35163094
PMCPMC8835203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.